Trial intelligence / Profile preview

Omega-3 and CoQ10 in Migraine

IRCT20090822002365N32Phase 3Completed

Sponsor
Iran University of Medical Sciences
Start
Apr 2025
Modality
Small Molecules
Countries
1
01

Overview

Phase 3 trial of omega-3 fatty acid and coenzyme q10 in migraine without aura and migraine with aura, sponsored by Iran University of Medical Sciences. Started Apr 2025; status: completed.

02

Drugs

omega-3 fatty acidcoenzyme q10
03

Conditions

migraine without auramigraine with aura

Beyond the preview

Go deeper on IRCT20090822002365N32.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT20090822002365N32.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call